Skip to main content
. 2017 Feb 3;12(2):e0171205. doi: 10.1371/journal.pone.0171205

Table 2. Adverse events.

Adverse Events n Severity Relationship to Study Treatment
Overall, treatment-related AEs 11 Grade 1: (9) Grade 2: (2) Probable/Certain (10) Possible (1)
Infusion-related reactions; pyrexia, chills, body ache 9 Grade 1: (7) Grade 2: (2) Probable/Certain
C-reactive protein increase 1 Grade 1: Mild Probable/Certain
Bronchitis 1 Grade 1: Mild Possible
Nasopharyngitis/viral infection 1 Grade 2 Unlikely
Headache 2 Grade 1–2 Unrelated
Hypertension 2 Grade 1–2 Unrelated
Fatigue 1 Grade 1: Mild Unrelated
Vomiting 1 Grade 1: Mild Unrelated
Insomnia 1 Grade 1: Mild Unrelated
Nicotine dependence 1 Grade 2: Moderate Unrelated
Blood cholesterol increase 1 Grade 1: Mild Unrelated
Acute coronary syndrome 1 Grade 3: Severe Unrelated